Biocartis Group NV
XBRU:BCART

Watchlist Manager
Biocartis Group NV Logo
Biocartis Group NV
XBRU:BCART
Watchlist
Price: 0.29 EUR Market Closed
Market Cap: 27.2m EUR
Have any thoughts about
Biocartis Group NV?
Write Note

Biocartis Group NV
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biocartis Group NV
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Biocartis Group NV
XBRU:BCART
Long-Term Debt
€101.8m
CAGR 3-Years
-14%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Nyxoah SA
XBRU:NYXH
Long-Term Debt
€11.5m
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Ion Beam Applications SA
XBRU:IBAB
Long-Term Debt
€29m
CAGR 3-Years
-24%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Sequana Medical NV
XBRU:SEQUA
Long-Term Debt
€12.3m
CAGR 3-Years
19%
CAGR 5-Years
38%
CAGR 10-Years
N/A
No Stocks Found

Biocartis Group NV
Glance View

Market Cap
27m EUR
Industry
Health Care

Biocartis Group NV which engages in the development of oncology molecular diagnostic solutions. The company is headquartered in Malines (Mechelen), Antwerpen and currently employs 619 full-time employees. The company went IPO on 2015-04-27. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.

BCART Intrinsic Value
0.94 EUR
Undervaluation 69%
Intrinsic Value
Price

See Also

What is Biocartis Group NV's Long-Term Debt?
Long-Term Debt
101.8m EUR

Based on the financial report for Jun 30, 2023, Biocartis Group NV's Long-Term Debt amounts to 101.8m EUR.

What is Biocartis Group NV's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
26%

Over the last year, the Long-Term Debt growth was -28%. The average annual Long-Term Debt growth rates for Biocartis Group NV have been -14% over the past three years , 26% over the past five years .

Back to Top